Atlas Trials

Liu Huang

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Liu Huang

RecordFirmDate
Fruquintinib vs Bevacizumab Combined With Irinotecan Liposome and Capecitabine as Second-Line Therapy for Advanced Metastatic Colorectal Cancer (NCT07051785)Liu Huang2025-07-07
An Exploratory Clinical Study Evaluating the Efficacy and Safety of Tunlametinib Combined With Fruquintinib in the Third-line Treatment of Advanced Colorectal Cancer Patients With RAS Mutations. (NCT06985316)Liu Huang2025-05-19
Glumetinib Combined With Fruquintinib in the Treatment of MET Amplification or Protein Overexpression in Third-Line Unresectable Metastatic Colorectal Cancer (NCT06980532)Liu Huang2025-04-25
Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC (NCT06551207)Liu Huang2024-08-20
Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer (NCT06199895)Liu Huang2023-11-28
Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing (NCT06413212)Liu Huang2023-08-04

Track Liu Huang automatically

Every clearance here is in the API, with alerts when new ones post.